APA Alıntı

Ganzinelli, M., Rulli, E., Caiola, E., Chiara Garassino, M., Broggini, M., Copreni, E., . . . Marabese, M. (2015). Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR). Sci Rep.

Chicago Stili Alıntı

Ganzinelli, Monica, et al. "Role of KRAS-LCS6 Polymorphism in Advanced NSCLC Patients Treated With Erlotinib or Docetaxel in Second Line Treatment (TAILOR)." Sci Rep 2015.

MLA Alıntı

Ganzinelli, Monica, et al. "Role of KRAS-LCS6 Polymorphism in Advanced NSCLC Patients Treated With Erlotinib or Docetaxel in Second Line Treatment (TAILOR)." Sci Rep 2015.